Page 334 - Industrial Ventilation Design Guidebook
P. 334

290                            CHAPTER 5 PHYSIOLOGICAL AND TOXICOLOGICAL CONSIDERATIONS

                  TABLE 5.12 Principal Assays in Genetic Toxicology

                    J. Pivotal assays
                        A. An assay for gene mutations
                               Salmonella/mammalian microsome assay (Ames test)
                        B. A mammalian assay for chromosome damage in vivo
                               Metaphase analysis or micronucleus assay in rodent bone marrow
                    II. Other assays offering an extensive database or unique endpoint
                        A. Assays for gene mutations
                               E. coli WP2 trytophan reversion assay
                               TK or HPRT forward mutation assays in cultured mammalian cells
                               Drosophila sex-linked recessive lethal assay
                        B. Cytogenetic analysis in cultured Chinese hamster or human cells
                               Assays for chromosome aberrations and micronuclei
                               Assays for aneuploidy
                        C. Other indicators of genetic damage
                               Assay for mitotic recombination in yeast and Drosophila
                               Assay for unscheduled DNA synthesis in cultured hepatocytes and
                            rodents
                        D. Mammalian germ cell assays
                               Mouse visible or electrophoretic specific-locus tests
                               Assays for skeletal and cataract mutations
                               Cytogenetic analysis and heritable translocation assays
                               DNA damage and repair in rodent germ cells
                               Dominant lethal assay
                     Source: Modified from Hoffmann, 1SI1



                  5.3.4.4 Target Organs
                     Organs as Targets of Chemical Compounds
                     Blood acts as the transport system for distribution of absorbed sub-
                  stances throughout the body. The distribution is often uneven. Adverse re-
                 sponses may occur if the concentration exceeds a critical concentration in the
                 target organ. As stated previously, the target organ is not necessarily the same
                 as the organ with the largest accumulation of the substance. Many corn-
                 pounds are stored in the skeleton and fatty tissue but critical effects usually
                 occur in other organs. Lipophilic organic materials are deposited in fatty tis-
                 sue, whereas some inorganic materials accumulate in the bones due to their
                 resemblance to calcium (e.g., lead) or their ability to bind with calcium (e.g.,
                 fluoride).  131 132
                            '
                     Water-soluble compounds are naturally easily transported in the blood.
                 Non-soluble compounds are usually transported bound to plasma proteins
                 (albumins). This binding is reversible in most cases but may vary remarkably.
                 The degree of protein binding may vary between 50% and 99%. The propor-
                 tion of the free (unbound) compound in the circulation is the amount of the
                 compound that can reach the tissues and thus the target organs. Very lipid-
   329   330   331   332   333   334   335   336   337   338   339